geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes


, : Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes. Diabetes Research and Clinical Practice 102(1): 16-24

To compare the efficacy and safety of acarbose plus metformin fixed-dose combination (FDC) versus acarbose monotherapy for type 2 diabetes (T2D). Eligible T2D patients undergoing treatment with diet control only or oral antidiabetic medications were run-in on acarbose 50mg thrice-daily for 4 weeks, then randomised either to continue this monotherapy, or to acarbose 50mg plus metformin hydrochloride 500mg FDC (acarbose/metformin FDC), each thrice-daily for 16 weeks. Acarbose/metformin FDC therapy significantly reduced HbA1c, fasting plasma glucose (FPG), and postprandial plasma glucose (PPG) from baseline (all p<0.0001) with superior efficacy compared with acarbose monotherapy (between-group differences; HbA1c -1.35%; FPG -29.5mg/dl; PPG -41.6mg/dl; all p<0.0001). Proportionally more patients treated with acarbose/metformin FDC achieved HbA1c <7.0% (47.8% vs. 10.7%, p<0.0001). Both treatments reduced bodyweight (p<0.0001), with a significant between-group difference (-0.6kg, p<0.01) favouring acarbose/metformin FDC. Hypoglycaemia was not reported with either treatment, and the incidence of other adverse events did not differ significantly between the groups. Compared with acarbose monotherapy, acarbose/metformin FDC has superior antihyperglycaemic efficacy, brings proportionally more T2D patients to HbA1c goal, and further reduces bodyweight. Acarbose/metformin FDC is well-tolerated without significant risk of hypoglycaemia and is a potentially advantageous therapy for T2D.

US$19.90

PMID: 23993469

DOI: 10.1016/j.diabres.2013.08.001


Other references

Anonymous, 1985: Generation and regulation of autocytotoxic cells in mixed lymphocyte culture evidence for suppression of autocytotoxic cells by limiting dilution analysis. Human Immunology 12(2): 117

Reinhart, G.J.; Xie, Q.; Liu, X-Jun.; Zhu, Y-Fei.; Fan, J.; Chen, C.; Struthers, R.Scott., 2004: Species selectivity of nonpeptide antagonists of the gonadotropin-releasing hormone receptor is determined by residues in extracellular loops II and III and the amino terminus. Efforts to develop orally available gonadotropin-releasing hormone (GnRH) receptor antagonists have led to the discovery of several classes of potent nonpeptide antagonists. Here we investigated molecular interactions of three classes of nonpeptid...

Kloppenburg, Sanneke, 2013: Mapping the Contours of Mobilities Regimes Air Travel and Drug Smuggling Between the Caribbean and the Netherlands. The problem of drug smuggling via air travel shapes the regulation of aeromobilities between the Caribbean and the Netherlands. On these routes, the international movement of people and goods needs to be facilitated, while restricting the movement...

Grinevich, A.G.; Zhivaeva, A.B., 1967: Some properties of local thermophilic strains of lactate bacteria Biology and physiology of microorganisms. Thirty local thermophillic strains of lactate bacteria were isolated. The antagonistic activity of the lactate bacteria was observed in relation to Escherichia coli and Sarcina lutea. The baculiforms of lactate bacteria were the most active^.

Powell, E.D.; Macdonald, D.Blair.; Elkeilani, A.M.; Asmis, T.R., 2009: A Case of Appendiceal Adenocarcinoma with Clinical Benefit from FOLFOX and Bevacizumab. A 44-year-old woman presented with lower abdominal pain and bilateral ovarian masses on ultrasound. Exploratory laparotomy revealed extensive peritoneal and intra-abdominal disease and an abnormal appendix. Bilateral salpingo-oophorectomy, infraco...

Bloom, P.H.; McCrary, M.D., 1996: The urban buteo: red-shouldered hawks in southern California. Unknown

Honda, Y.; Higaki, T.; Higashihori, H.; Monzen, Y.; Tatsugami, F.; Date, S.; Awai, K., 2015: Re-evaluation of detectability of liver metastases by contrast-enhanced CT: added value of hepatic arterial phase imaging. We compared the detectability of liver metastases on 2- and 3-phase images using robust statistical methods. Nine radiologists evaluated unenhanced CT plus portal venous phase (2-phase) images and 2-phase plus hepatic arterial phase (HAP) (3-phase...

Kahuda, F., 1979: Model MIR of the cerebral time-space. Casopis Lekaru Ceskych 118(2): 38-46

D.P.erro, M.; Lu, R.; Uzzau, S.; Wang, W.; Maimone, F.; Fasano, A., 2000: Zonula occludens toxin Characterization of C-terminal fragment biological activity. JPGN 31(Supplement 2): S280

L.P.ge, Cécile.; Provencher, D.; Maugard, C.M.; Ouellet, Véronique.; Mes-Masson, A-Marie., 2004: Signature of a silent killer: expression profiling in epithelial ovarian cancer. With the sequencing of the human genome and the simultaneous development of high-throughput strategies, cancer biologists have entered an exciting new area for gene expression analysis, with the ability to glimpse higher order patterns of genetic...